Key Benefits

• Estimate your current egg supply; AMH reflects the number of remaining follicles.
• Guide family planning timelines by showing age-adjusted reserve above, average, or low.
• Personalize egg-freezing or IVF plans by predicting ovarian response to stimulation.
• Spot possible PCOS or diminished reserve when AMH is unusually high or low.
• Protect fertility decisions before chemo or ovarian surgery by assessing baseline reserve.
• Track reserve trends to clarify decline rate and approximate menopause timing trajectory.
• Clarify expectations: AMH reflects egg quantity, not egg quality or monthly fertility.
• Interpret results alongside pelvic ultrasound (antral follicle count), age, and your goals.

What is an AMH (anti-Müllerian hormone) blood test?

Anti-Müllerian hormone is a signaling protein made by the ovaries’ small, growing egg sacs (granulosa cells of preantral and small antral follicles). It’s called “anti-Müllerian” because, in male embryos, AMH from the testes causes the Müllerian ducts to regress, shaping male internal anatomy (Sertoli cells; Müllerian duct regression). In everyday blood testing for adults, AMH mainly reflects ovarian production and is released steadily, changing little across the menstrual cycle.

In the ovary, AMH helps set the pace of follicle development—acting as a local brake that influences how many follicles enter growth and how sensitive they are to pituitary signals (follicular recruitment; FSH sensitivity). Measuring AMH in blood gives a snapshot of how many small follicles are actively present, offering a biological read on the ovaries’ egg supply and activity (ovarian reserve; growing follicle pool). This captures the living, working portion of the ovary rather than the silent store, and helps indicate how the ovary may respond to hormonal cues. In early life and in males, AMH mainly reflects activity of the testicular supporting cells that guide development (Sertoli cell function), explaining the hormone’s name and broader biological role.

Why is an AMH (anti-Müllerian hormone) blood test important?

AMH (anti-Müllerian hormone) is a signal from the gonads about how many immature follicles or Sertoli cells are active. In women it reflects the size of the ovarian follicle pool and how responsive the ovary is to pituitary signals; in males, it reflects Sertoli cell function in the testes. Because it links the ovary or testis to the brain’s reproductive axis, AMH informs fertility potential, pubertal development, and, indirectly, lifelong bone and metabolic health.

Typical values vary by age and lab. In women, levels peak in early adulthood and steadily fall toward menopause; for most, an age-appropriate middle range is expected. In infancy boys have high levels that decline toward low adult male values; girls have low levels in childhood that rise with puberty.

When AMH is low in women, it usually means fewer recruitable follicles—diminished ovarian reserve—from aging or primary ovarian insufficiency. Cycles may shorten or become irregular, and there can be fertility challenges; if estrogen falls early, hot flashes and downstream risks to bone and cardiovascular health may follow. During pregnancy, AMH naturally runs lower. In infants and boys, very low AMH can indicate absent or poorly functioning testes.

When AMH is high in women, it often reflects many small follicles, as seen in polycystic ovary syndrome, with irregular or absent ovulation, acne or excess hair, and increased risks of insulin resistance. Markedly elevated results can be a tumor marker for granulosa cell tumors.

Big picture: AMH connects ovarian or testicular biology to the brain, metabolism, and aging. It complements gonadotropins, sex steroids, ultrasound findings, and clinical history to clarify reproductive timing, detect disorders like PCOS or gonadal dysgenesis, and anticipate health risks tied to the sex-steroid milieu.

What insights will I get?

AMH is a hormone from small growing ovarian follicles; the blood test estimates the size of the remaining follicle pool (ovarian reserve). It reflects reproductive timeline, cycle robustness, and endocrine signaling. In males and children, AMH from Sertoli cells indexes testicular development. It does not measure egg quality or guarantee pregnancy but helps predict ovarian response to stimulation.

Low values usually reflect a smaller pool of recruitable follicles (diminished ovarian reserve), most often with advancing age and near menopause. They can also follow ovarian surgery, chemotherapy, or genetic ovarian disorders. During pregnancy and with some hormonal contraceptives, AMH often reads lower because follicle recruitment is suppressed. In boys, low AMH can signal impaired Sertoli cell function.

Being in range suggests an age-appropriate number of small follicles and steady ovarian signaling, supporting regular cycles and a predictable response to fertility medications if needed. In children and men, age‑appropriate AMH supports normal Sertoli cell activity. For premenopausal women, typical results sit near the mid‑range for age.

High values usually reflect a larger count of small follicles, often seen in polycystic ovary syndrome, where follicle maturation is stalled. This can associate with irregular cycles and androgen excess. Markedly high results can occur with rare granulosa cell tumors. In male infants and boys, high AMH can be physiologic.

Notes: Interpretation is age‑ and assay‑dependent; reference intervals vary by lab. AMH is relatively stable across the menstrual cycle but can be lower in pregnancy and with hormonal contraception. Pair with clinical history, ultrasound, and other hormones for context.